Article

DOD opens refractive surgery center in Texas

The first Department of Defense (DOD) Joint Warfighter Refractive Surgery Center opened Aug. 23 at Wilford Hall Medical Center (59th Medical Wing), Lackland Air Force Base.

San Antonio, TX-The first Department of Defense (DOD) Joint Warfighter Refractive Surgery Center opened Aug. 23 at Wilford Hall Medical Center (59th Medical Wing), Lackland Air Force Base.

"Every year, the U.S. Air Force spends billions of dollars upgrading the capabilities of our weapons systems, like upgrading avionics on the F-16 or F-22," said Charles D. Reilly, MD, a lieutenant colonel, chief of the center, and consultant to the Air Force surgeon general for refractive surgery. "The new laser ambulatory surgery center brings the latest state-of-the art technology to allow us to upgrade the avionics of our most important weapons system-our people."

The $2.7 million renovated facility contains three temperature- and humidity-controlled laser surgery suites and adds eight Air Force and Army surgeons. The center is the only one authorized to perform LASIK on Air Force pilots; runs the only Air Force residency program in ophthalmology, which is the DOD's largest ophthalmology residency program; and, through a program with the University of Texas Health Science Center, also provides training in refractive surgery to civilian ophthalmology residents.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.